Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (2) Berruezo Llacuna, Maria (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Blankenstein, Thomas Prof. Dr. (2) Bunse, Mario Dr. (1) Caganova, Marieta Dr. (1) Clauß, Julian (1) Costanza, Mariantonia (1) Diecke, Sebastian Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Gerhardt, Holger Prof. Dr. (1) Graf, Robin Dr. (2) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (2) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (2) Kärgel, Eva Dr. (1) Kastelic, Nicolai (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kirchner, Marieluise Dr. (2) Kocks, Christine Dr. (1) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (2) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Menzel, Lutz Peter Dr. (1) Mertins, Philipp Dr. (1) Milek, Miha Dr. (2) Obenaus, Matthias (1) Pezzutto, Antonio Prof. Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rahjouei, Ali Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rehm, Armin Dr. (2) Rhein, Simone Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (15) Szymborska-Mell, Anna Bozena Dr. (1) Uckert, Wolfgang Prof. Dr. (14) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (2) Wolf, Susanne Dr. (1) Zauber, Henrik Dr. (4) (-) Mathas, Stephan Dr. (8) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) (-) 2004 (2) 2005 (2) 2006 (5) (-) 2007 (3) 2008 (5) 2009 (3) 2010 (7) 2011 (5) 2012 (4) 2013 (1) 2014 (4) 2016 (4) 2017 (5) (-) 2018 (1) 2019 (2) (-) 2020 (2) 2021 (3) 2022 (4) (-) Biology of Malignant Lymphomas (8) Mechanism-based Cancer Therapies (2) Molecular Immunology and Gene Therapy (2) Signal Transduction in Tumor Cells (1) Systems Biology of Gene Regulatory Elements (1) 8 Results: Active Filter: Mathas, Stephan Dr.Biology of Malignant Lymphomas2004200720182020 Sort: Result score Newest to oldest Oldest to newest December 17, 2020 in Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper June 01, 2020 in JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert September 01, 2018 in Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken January 01, 2004 in Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
December 17, 2020 in Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper
June 01, 2020 in JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert
September 01, 2018 in Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
January 01, 2004 in Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
